Phase I trial of three-weekly docetaxel, carboplatin and oral CC-5013 in patients with advanced solid tumours.
Phase of Trial: Phase I
Latest Information Update: 11 Jul 2011
At a glance
- Drugs Lenalidomide (Primary) ; Carboplatin; Docetaxel
- Indications Solid tumours
- Focus Adverse reactions
- 11 Jul 2011 Status changed from active, no longer recruiting to completed.
- 07 Jul 2011 Lead trial centers added as reported by ClinicalTrials.gov.
- 07 Jul 2011 Actual end date (Jul 2007) added as reported by ClinicalTrials.gov.